Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alan

Showing results (301-310 of 382) with videos related to

Pageof 39
Sort By:
Pharmacoepidemiology and Drug Safety|May 27, 2005
Educational outreach (academic detailing) regarding osteoporosis in primary careJennifer M Polinski, M Alan Brookhart, Jeffrey N Katz, et al.
Clinical Epidemiology|March 30, 2026
Real-World Comparability of Antiresorptive Osteoporosis Treatment Groups Among Treatment-Naïve and Treatment-Experienced Women Ages 55 and Older in the United StatesKathleen E Hurwitz, Lydia Feinstein, David A Pritchard, et al.
Health Affairs (Project Hope)|July 8, 2010
State generic substitution laws can lower drug outlays under MedicaidWilliam H Shrank, Niteesh K Choudhry, Jessica Agnew-Blais, et al.
Arthritis and Rheumatism|March 30, 2011
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Karen H Costenbader, Amrita Desai, Graciela S Alarcón, et al.
Drugs|March 25, 2010
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysisAaron S Kesselheim, Margaret R Stedman, Ellen J Bubrick, et al.
Journal of Endocrinological Investigation|June 30, 2018
Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndromeM Bicer, M Alan, P Alarslan, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Trends in Pediatric Emergency and Inpatient Healthcare Use for Mental and Behavioral Health Among North Carolinians During the Early COVID-19 PandemicRachel Sielaty, Angelique E Boutzoukas, Kanecia O Zimmerman, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapiesSara N Levintow, Kate K Orroth, Alexander Breskin, et al.
Patient Preference and Adherence|February 6, 2020
Effects of Estimated Community-Level Health Literacy on Treatment Initiation and Preventive Care Among Older Adults with Newly Diagnosed DiabetesGang Fang, Stacy Cooper Bailey, Izabela E Annis, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2020
Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United StatesLeah J McGrath, Leslie Spangler, Jeffrey R Curtis, et al.
Pageof 39

Showing results (301-310 of 382) with videos related to

Sort By:
Pageof 39
Pharmacoepidemiology and Drug Safety|May 27, 2005
Educational outreach (academic detailing) regarding osteoporosis in primary careJennifer M Polinski, M Alan Brookhart, Jeffrey N Katz, et al.
Clinical Epidemiology|March 30, 2026
Real-World Comparability of Antiresorptive Osteoporosis Treatment Groups Among Treatment-Naïve and Treatment-Experienced Women Ages 55 and Older in the United StatesKathleen E Hurwitz, Lydia Feinstein, David A Pritchard, et al.
Health Affairs (Project Hope)|July 8, 2010
State generic substitution laws can lower drug outlays under MedicaidWilliam H Shrank, Niteesh K Choudhry, Jessica Agnew-Blais, et al.
Arthritis and Rheumatism|March 30, 2011
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Karen H Costenbader, Amrita Desai, Graciela S Alarcón, et al.
Drugs|March 25, 2010
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysisAaron S Kesselheim, Margaret R Stedman, Ellen J Bubrick, et al.
Journal of Endocrinological Investigation|June 30, 2018
Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndromeM Bicer, M Alan, P Alarslan, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Trends in Pediatric Emergency and Inpatient Healthcare Use for Mental and Behavioral Health Among North Carolinians During the Early COVID-19 PandemicRachel Sielaty, Angelique E Boutzoukas, Kanecia O Zimmerman, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapiesSara N Levintow, Kate K Orroth, Alexander Breskin, et al.
Patient Preference and Adherence|February 6, 2020
Effects of Estimated Community-Level Health Literacy on Treatment Initiation and Preventive Care Among Older Adults with Newly Diagnosed DiabetesGang Fang, Stacy Cooper Bailey, Izabela E Annis, et al.
Pharmacoepidemiology and Drug Safety|June 16, 2020
Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United StatesLeah J McGrath, Leslie Spangler, Jeffrey R Curtis, et al.
Pageof 39